Coach vs. Kors: Bat...
DexCom Inc. (DXCM: NASDAQ)
$10.71 -0.06 | -0.56%
06/04/12 - 09:54 AM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -44.75M | -55.17M | -53.52M | -55.18M |
| Operating Gains/Losses | 22.00K | 8.59M | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -5.88M | -3.18M | -2.37M | -903.00K |
| (Increase) Decrease in Inventories | -59.00K | -5.47M | -195.00K | -1.31M |
| (Increase) Decrease In Other Current Assets | 775.00K | 0.00 | 0.00 | -3.36M |
| (Decrease) Increase In Payables | 996.00K | -432.00K | 1.51M | -291.00K |
| (Decrease) Increase In Other Current Liabilities | 1.07M | 1.32M | 2.29M | -422.00K |
| (Increase) Decrease In Other Working Capital | -1.73M | -3.32M | -2.47M | 12.24M |
| Other Non-Cash Items | 13.51M | 11.22M | 13.76M | 8.04M |
| Net Cash From Continuing Operations | -30.13M | -42.68M | -39.39M | -37.45M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -30.13M | -42.68M | -39.39M | -37.45M |
| Sale of Property, Plant & Equipment | 4.00K | 6.00K | 302.00K | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 64.29M | 54.69M | 53.86M | 63.80M |
| Purchases of Property, Plant & Equipment | -8.01M | -6.86M | -2.99M | -2.49M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -102.66M | -73.45M | -65.27M | -36.99M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -46.37M | -25.61M | -14.10M | 24.32M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 3.00M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 74.71M | 70.55M | 46.31M | 1.76M |
| Repayment of Long-Term Debt | -525.00K | -900.00K | -1.93M | -2.05M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 74.18M | 69.65M | 44.38M | 2.71M |
| Effect of Exchange Rate Changes | -23.00K | -48.00K | -9.00K | 0.00 |
| Net Change in Cash & Cash Equivalents | -2.34M | 1.31M | -9.12M | -10.42M |
Portfolios with DXCM
- Portfolio NameUser Type
- ContributorUnder-$10 Setting Up To Tra...
- UserWatch 1 - Breakout
- ContributorBreakout Stocks Of The Week...
- ContributorBarron's Insider Purchases ...
- UserPART 3 JPMorgan 28th Annual...
- UserLast Day of the JPMorgan He...
- UserPART 7 JPMorgan 26th Annual...
- Userheld_2long
- Userusa9 Portfolio 1
- UserSyOps Portfolio 1
Latest DXCM Headlines from TheStreet
- 5 Under-$10 Stocks Set to Soar 12.29.11 | 06:12 pm
- DexCom Stock Hits New 52-Week Low (DXCM) 11.21.11 | 10:11 am
- DexCom Stock Hits New 52-Week Low (DXCM) 11.08.11 | 10:11 am
- DexCom Stock Gaps Down On Today's Open (DXCM) 11.03.11 | 09:11 am
- DexCom Stock Hits New 52-Week Low (DXCM) 10.27.11 | 02:10 pm
- DexCom Stock Falls On Unusually High Volume (DXCM) 08.04.11 | 02:08 pm
- DexCom Stock Falls On Unusually High Volume (DXCM) 05.05.11 | 01:05 pm
- DexCom CEO Discusses Q3 2010 Results - Earnings Call Transcript 11.07.10 | 02:11 pm
- Breakout Stocks: SPDR Gold Trust, Netflix 08.16.10 | 03:08 pm
- DexCom, Inc.Q2 2010 Earnings Call Transcript 08.04.10 | 01:08 am
Press Releases for DXCM
- Dexcom To Present At The Deutsche Bank 37th Annual Healthcare Conference - Business Wire 04.26.12 | 08:04 am
- Dexcom Schedules First Quarter 2012 Earnings Release And Conference Call For May 2, 2012 - Business Wire 04.25.12 | 08:04 am
- Dexcom To Present At The Barclays Capital Global Healthcare Conference - Business Wire 03.06.12 | 08:03 am
- DexCom, Inc. Reports Fourth Quarter And Full Year 2011 Financial Results - Business Wire 02.23.12 | 04:02 pm
- DexCom, Inc. Announces Acquisition Of SweetSpot Diabetes Care, Inc. - Business Wire 02.23.12 | 04:02 pm
- Dexcom Schedules Fourth Quarter And Full Year 2011 Earnings Release And Conference Call For February 23, 2012 - Business Wire 02.14.12 | 09:02 am
- DexCom And Tandem Diabetes Care Announce CGM Development And Commercialization Agreement - Business Wire 02.02.12 | 08:02 am
- Dexcom To Present At The 30th Annual J.P. Morgan Healthcare Conference - Business Wire 01.03.12 | 04:01 pm
- DexCom To Present At Upcoming Investor Conferences - Business Wire 11.07.11 | 04:11 pm
- DexCom To Present At Upcoming Investor Conferences - Business Wire 11.07.11 | 05:11 am
Partner Headlines for DXCM
- DexCom Misses on EPS, Losses Mount - Analyst Blog - Zacks 05.07.12 | 10:05 am
- UPDATE: Brean Murray Carret Raises Target on DexCom to $13.50 - Benzinga 02.24.12 | 04:02 pm
- UPDATE: Wunderlich Securities Raises Price Target on DexCom to $15 - Benzinga 02.24.12 | 09:02 am
- UPDATE: Feltl & Co Upgrades DexCom from Hold to Buy and Lowers PT from $15.85 to $15.35 - Benzinga 08.16.11 | 09:08 am
- DexCom Reaffirmed Neutral - Analyst Blog - Zacks 05.26.11 | 06:05 pm
- Contrarian Ideas: 20 Healthcare Stocks With Low Put/Call Ratios - Seeking Alpha 01.18.11 | 07:01 am
- DexCom shares plunge after FDA seeks more data on products - Reuters 11.05.10 | 12:11 pm
- William Blair Reiterates Outperform on DexCom (DXCM) - Benzinga 08.04.10 | 09:08 am
- M&A Market: Potential Acquisition Plays in Each Sector - Seeking Alpha 07.06.10 | 06:07 am
- DexCom Misses Zacks Consensus - Analyst Blog - Zacks 05.13.10 | 02:05 pm





